%0 Journal Article
%T 5-羟色胺与硬皮病<br>Serotonin and Scleroderma
%A 黄建国
%A 龚启英
%A 黄朝頔
%A 李桂明
%J Hans Journal of Medical Cosmetology
%P 1-5
%@ 2332-6921
%D 2013
%I Hans Publishing
%R 10.12677/HJMC.2013.11001
%X <p align=\"justify\">
	硬皮病是自身免疫性疾病之一，以血管功能障碍、炎症和皮肤硬化为特征。5-羟色胺(5-HT)作为血管活性胺类物质</a>，炎症介质能刺激真皮成纤维细胞增殖；5-HT/5-HT2B信号通过调控血管损伤和血小板活性从而与皮肤组织纤维化有关联。临床上采用5-HT3受体抑制剂托烷司琼(tropisetron)治疗硬皮病患者取得明显效果。研究5-HT与硬皮病的关系对治疗硬皮病将开辟一条新的途径。
</p>
<p align=\"justify\">
	Scleroderma is one of the autoimmune diseases characterized by inflammation, vascular dysfunction and skin sclerosis. As the vasoactive amine substances and inflammatory mediators, serotonin (5-HT) can stimulate the dermal fibroblast proliferation; 5-HT/5-HT2B signal are associated with skin tissue fibrosis through regulating vascular injury and platelet activity. The clinical application of tropisetron (5-HT3 receptor inhibitor) obtains obvious effects in the treatment of patients with scleroderma. Study on the relationship between 5-HT and scleroderma will inaugurate a new way for the treatment of scleroderma.
</p>
<p>
	&nbsp;
</p>
%K 5-羟色胺；硬皮病<br>Serotonin
%K Scleroderma
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=12461